| Spleen tyrosine kinase–mediated autophagy is required for epithelial–mesenchymal plasticity and metastasis in breast cancer A Shinde, SD Hardy, D Kim, SS Akhand, MK Jolly, WH Wang, ... Cancer research 79 (8), 1831-1843, 2019 | 109 | 2019 |
| Selection of DNA-encoded Libraries to Protein Targets Within and On Living Cells CK Bo Cai, Dongwook Kim, Saeed Akhand, Yixing Sun, Robert Cassell, Aktan ... J. Am. Chem. Soc., 2019 | 98 | 2019 |
| FGFR signaling maintains a drug persistent cell population following epithelial-mesenchymal transition WS Brown, SS Akhand, MK Wendt Oncotarget 7 (50), 83424, 2016 | 53 | 2016 |
| Epigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer A Abdullah, SS Akhand, JSP Paez, W Brown, L Pan, S Libring, M Badamy, ... Oncogene 40 (2), 322-333, 2021 | 32 | 2021 |
| Pharmacologic inhibition of FGFR modulates the metastatic immune microenvironment and promotes response to immune checkpoint blockade SS Akhand, Z Liu, SC Purdy, A Abdullah, H Lin, GM Cresswell, TL Ratliff, ... Cancer immunology research 8 (12), 1542-1553, 2020 | 26 | 2020 |
| Fibroblast growth factor receptor facilitates recurrence of minimal residual disease following trastuzumab emtansine therapy SS Akhand, H Chen, SC Purdy, Z Liu, JC Anderson, CD Willey, MK Wendt NPJ Breast Cancer 7 (1), 5, 2021 | 19 | 2021 |
| MgtE is a dual-function protein in Pseudomonas aeruginosa BM Coffey, SS Akhand, GG Anderson Microbiology 160 (6), 1200-1213, 2014 | 16 | 2014 |
| New treatments in development for Pseudomonas aeruginosa infections in the lungs of individuals with cystic fibrosis SS Akhand, RS Pettit, TE Gardner, GG Anderson Orphan Drugs: Research and Reviews, 71-81, 2014 | 7 | 2014 |
| Nonclinical pharmacokinetics and biodistribution of VSV-GP using methods to decouple input drug disposition and viral replication R Dambra, A Matter, K Graca, SS Akhand, S Mehta, A Bell-Cohn, ... Molecular Therapy Methods & Clinical Development 28, 190-207, 2023 | 4 | 2023 |
| Targeting FGFR for the treatment of breast cancer R Ali, SS Akhand, MK Wendt Resistance to Targeted Therapies in Breast Cancer, 117-137, 2017 | 3 | 2017 |
| Fibroblast growth receptor 1 is regulated by G-quadruplex in metastatic breast cancer H Lin, M Hassan Safdar, S Washburn, S S. Akhand, J Dickerhoff, M Ayers, ... Communications Biology 7 (1), 963, 2024 | | 2024 |
| Abstract PO2-18-06: Targeting fibroblast growth factor receptor (FGFR1) expression through G-quadruplex stabilization inhibits metastatic breast cancer M Safdar, H Lin, S Dagher, J Dickerhoff, M Ayers, L Solorio, D Yang, ... Cancer Research 84 (9_Supplement), PO2-18-06-PO2-18-06, 2024 | | 2024 |
| Abstract ND01: ABBV-303: A novel NK and CD8 T cell engager specific for c-Met-expressing tumors J Stone, KP Fish, D Ashok, L McKay, S Akhand, W Zhao, S Wu, ... Cancer Research 84 (7_Supplement), ND01-ND01, 2024 | | 2024 |
| Readiness for Safety and PK/BD Studies in Tumor Bearing Models for VSV-GP Oncolytic Virus A Brenot, A Mikolaichik, J Kim, R Dambra, K Graca, S Akhand, J Ashour, ... INTERNATIONAL JOURNAL OF TOXICOLOGY 42 (1), 94-94, 2023 | | 2023 |
| Correction: Epigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer A Abdullah, SS Akhand, JSP Paez, W Brown, L Pan, S Libring, M Badamy, ... Oncogene 42 (17), 1418, 2023 | | 2023 |
| Pharmacokinetics and Biodistribution of VSV-GP Using Methods to Decouple Input Drug Disposition and Replication Dynamics in Mice R Dambra, A Matter, K Graca, JM Swenson, A Bell-Cohn, SS Akhand, ... MOLECULAR THERAPY 30 (4), 322-323, 2022 | | 2022 |
| PHARMACOLOGICAL TARGETING OF FGFR SIGNALING TO INHIBIT BREAST CANCER RECURRENCE AND METASTASIS SS Akhand Purdue University Graduate School, 2020 | | 2020 |
| Inhibition of FGFR in breast cancer metastasis H Lin, SS Akhand, MK Wendt Cancer Research 78 (13_Supplement), 4782-4782, 2018 | | 2018 |
| Effect of BET inhibitor in drug resistant breast cancer LA Acevedo-Soto, S Akhand, M Wendt ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 253, 2017 | | 2017 |
| Abstract B47: Drug-induced EMT is fundamentally distinct from pathologic EMT SS Akhand, M Wendt Cancer Research 76 (7_Supplement), B47-B47, 2016 | | 2016 |
